Form 8-K - Current report:
SEC Accession No. 0001193125-25-137089
Filing Date
2025-06-06
Accepted
2025-06-06 16:22:22
Documents
12
Period of Report
2025-06-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d39292d8k.htm   iXBRL 8-K 28119
  Complete submission text file 0001193125-25-137089.txt   143925

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pstv-20250603.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20250603_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20250603_pre.xml EX-101.PRE 11279
15 EXTRACTED XBRL INSTANCE DOCUMENT d39292d8k_htm.xml XML 3658
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 251031012
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)